JSR Life Sciences Acquires Selexis

(c) Lichtmeister/Shutterstock
(c) Lichtmeister/Shutterstock

JSR Life Sciences has acquired Swiss biotech Selexis for an undisclosed sum. The Geneva-headquartered company is the global leader in mammalian cell-line generation technologies and will boost JSR’s ability to develop and produce more high-quality biologics at a faster rate.

Selexis will be integrated within KBI Biopharma, a US-based contract development and manufacturing organization (CDMO) that JSR acquired in 2015.

“Combining KBI’s robust analytical, process development and reliable high-quality manufacturing capabilities with our Selexis SUREtechnology platform puts us in a position to offer current and future partners the ability to take their R&D programs from transfection to investigational new drug applications in less than nine months,” said Igor Fisch, CEO of Selexis. “By delivering the fastest timelines in the industry, our partners will benefit from substantial cost savings and patients will have access to critical drugs sooner.”

The two groups have a long history of collaboration, and KBI has performed development and/or manufacturing services using more than 15 different cell lines generated by Selexis since 2012.

Last month, KBI announced that it had agreed to buy the assets of San Diego-based Alliance Protein Laboratories, a leading analytical services company that specializes in biophysical characterization of biopharmaceuticals.

CDMO is also expanding its biopharmaceutical manufacturing capacities in Durham, North Carolina, and Boulder, Colorado, with completion due later this year.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.